• 239 Citations
  • 5 h-Index
20082015
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Amy Barnett is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Phosphatidylinositol 3-Kinases Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Receptor Protein-Tyrosine Kinases Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
Apoptosis Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Amifostine Medicine & Life Sciences

Research Output 2008 2015

  • 239 Citations
  • 5 h-Index
  • 7 Article
18 Citations (Scopus)

Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST)

Mahadevan, D., Theiss, N., Morales, C., Stejskal, A. E., Cooke, L. S., Zhu, M., Kurtzman, D., Swart, R., Ong, E. & Qi, W., Jan 1 2015, In : Oncotarget. 6, 4, p. 1954-1966 13 p.

Research output: Contribution to journalArticle

Open Access
Gastrointestinal Stromal Tumors
Receptor Protein-Tyrosine Kinases
Therapeutics
Stromal Cells
Imatinib Mesylate
43 Citations (Scopus)

Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma

Mahadevan, D., Stejskal, A., Cooke, L. S., Manziello, A., Morales, C., Persky, D. O., Fisher, R. I., Miller, T. P. & Qi, W., Apr 15 2012, In : Clinical Cancer Research. 18, 8, p. 2210-2219 10 p.

Research output: Contribution to journalArticle

Open Access
docetaxel
Vincristine
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Neoplasms
68 Citations (Scopus)

Phase i pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies

Mahadevan, D., Chiorean, E. G., Harris, W. B., Von Hoff, D. D., Stejskal-Barnett, A., Qi, W., Anthony, S. P., Younger, A. E., Rensvold, D. M., Cordova, F., Shelton, C. F., Becker, M. D., Garlich, J. R., Durden, D. L. & Ramanathan, R. K., Dec 1 2012, In : European Journal of Cancer. 48, 18, p. 3319-3327 9 p.

Research output: Contribution to journalArticle

Prodrugs
Phosphatidylinositol 3-Kinases
Blood Vessels
B-Lymphocytes
Pharmacokinetics
2 Citations (Scopus)

SF1126, a Pan-PI3K inhibitor has potent pre-clinical activity in aggressive B-cell non-Hodgkin lymphomas by inducing cell cycle arrest and apoptosis

Qi, W., Stejskal, A., Morales, C., Cooke, L. S., Garlich, J. R., Durden, D. & Mahadevan, D., Sep 17 2012, In : Journal of Cancer Science and Therapy. 4, 7, p. 207-213 7 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Cell Cycle Checkpoints
Phosphatidylinositol 3-Kinases
Non-Hodgkin's Lymphoma
Apoptosis

Radioprotection from radiation-induced lymphedema without tumor protection

Daley, S. K., Bernas, M. J., Stea, B. D., Bracamonte, E., McKenna, M., Stejskal, A., Hirleman, E. D. & Witte, M. H., Jun 1 2010, In : Lymphology. 43, 2, p. 48-58 11 p.

Research output: Contribution to journalArticle

Amifostine
Lymphedema
Radiotherapy
Radiation
Neoplasms